Trial Profile
Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2022
Price :
$35
*
At a glance
- Drugs Lofexidine (Primary)
- Indications Renal impairment
- Focus Pharmacokinetics
- Sponsors US WorldMeds
- 22 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Dec 2014 New trial record